Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Laryngeal mucous membrane plasmacytosis with 15 year follow-up: Case report and literature review.

Makarenko VV, Vaezi AE, Brettler DB, Hutchinson L, Woda BA, Chen BJ.

Leuk Res Rep. 2019 Nov 27;13:100190. doi: 10.1016/j.lrr.2019.100190. eCollection 2020.

2.

Somatic molecular analysis augments cytologic evaluation of pancreatic cyst fluids as a diagnostic tool.

Sakhdari A, Moghaddam PA, Ok CY, Walter O, Tomaszewicz K, Caporelli ML, Meng X, LaFemina J, Whalen G, Belkin E, Zivny J, Wassef W, Woda BA, Hutchinson LM, Cosar EF.

Oncotarget. 2019 Jun 18;10(40):4026-4037. doi: 10.18632/oncotarget.26999. eCollection 2019 Jun 18.

3.

Next-Generation Sequencing to Detect Deletion of RB1 and ERBB4 Genes in Chromophobe Renal Cell Carcinoma: A Potential Role in Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma.

Liu Q, Cornejo KM, Cheng L, Hutchinson L, Wang M, Zhang S, Tomaszewicz K, Cosar EF, Woda BA, Jiang Z.

Am J Pathol. 2018 Apr;188(4):846-852. doi: 10.1016/j.ajpath.2017.12.003. Epub 2018 Jan 31.

4.

Phosphorylation of the Mdm2 oncoprotein by the c-Abl tyrosine kinase regulates p53 tumor suppression and the radiosensitivity of mice.

Carr MI, Roderick JE, Zhang H, Woda BA, Kelliher MA, Jones SN.

Proc Natl Acad Sci U S A. 2016 Dec 27;113(52):15024-15029. doi: 10.1073/pnas.1611798114. Epub 2016 Dec 12.

5.

PD-L1 expression in EBV-negative diffuse large B-cell lymphoma: clinicopathologic features and prognostic implications.

Xing W, Dresser K, Zhang R, Evens AM, Yu H, Woda BA, Chen BJ.

Oncotarget. 2016 Sep 13;7(37):59976-59986. doi: 10.18632/oncotarget.11045.

6.

Immunohistochemical loss of 5-hydroxymethylcytosine expression in acute myeloid leukaemia: relationship to somatic gene mutations affecting epigenetic pathways.

Magotra M, Sakhdari A, Lee PJ, Tomaszewicz K, Dresser K, Hutchinson LM, Woda BA, Chen BJ.

Histopathology. 2016 Dec;69(6):1055-1065. doi: 10.1111/his.13046. Epub 2016 Sep 23.

PMID:
27458708
7.

Role of Tetrasomy for the Diagnosis of Urothelial Carcinoma Using UroVysion Fluorescent In Situ Hybridization.

Zhou AG, Liu Y, Cyr MS, Garver J, Woda BA, Cosar EF, Hutchinson LM.

Arch Pathol Lab Med. 2016 Jun;140(6):552-9. doi: 10.5858/arpa.2015-0109-OA.

PMID:
27232347
8.

Mild Microcytic Anemia in an Infant with a Compound Heterozygosity for Hb C (HBB: c.19G > A) and Hb Osu Christiansborg (HBB: c.157G > A).

Boucher MO, Chui DH, Woda BA, Newburger PE.

Hemoglobin. 2016 Jun;40(3):208-9. doi: 10.3109/03630269.2016.1165245.

PMID:
27117572
9.

MYC Immunohistochemistry to Identify MYC-Driven B-Cell Lymphomas in Clinical Practice.

Kluk MJ, Ho C, Yu H, Chen BJ, Neuberg DS, Dal Cin P, Woda BA, Pinkus GS, Rodig SJ.

Am J Clin Pathol. 2016 Feb;145(2):166-79. doi: 10.1093/ajcp/aqv028. Epub 2016 Feb 1.

PMID:
26834124
10.

Hemophagocytic lymphohistiocytosis secondary to T-cell/histiocyte-rich large B-cell lymphoma.

Devitt K, Cerny J, Switzer B, Ramanathan M, Nath R, Yu H, Woda BA, Chen BJ.

Leuk Res Rep. 2014 Jun 2;3(2):42-5. doi: 10.1016/j.lrr.2014.05.004. eCollection 2014.

11.

IMP3 expression is associated with poor outcome and epigenetic deregulation in intrahepatic cholangiocarcinoma.

Gao Y, Yang M, Jiang Z, Woda BA, Mercurio AM, Qin J, Huang X, Zhang F.

Hum Pathol. 2014 Jun;45(6):1184-91. doi: 10.1016/j.humpath.2014.01.016. Epub 2014 Feb 6.

12.

Oncofetal protein IMP3, a new cancer biomarker.

Gong Y, Woda BA, Jiang Z.

Adv Anat Pathol. 2014 May;21(3):191-200. doi: 10.1097/PAP.0000000000000021. Review.

PMID:
24713990
13.

MYC protein expression is detected in plasma cell myeloma but not in monoclonal gammopathy of undetermined significance (MGUS).

Xiao R, Cerny J, Devitt K, Dresser K, Nath R, Ramanathan M, Rodig SJ, Chen BJ, Woda BA, Yu H.

Am J Surg Pathol. 2014 Jun;38(6):776-83. doi: 10.1097/PAS.0000000000000213.

PMID:
24705315
14.

Five important advances in hematopathology.

Shi M, Xiao R, Woda BA, Yu H.

Arch Pathol Lab Med. 2014 Mar;138(3):410-9. doi: 10.5858/ARPA.2012-0645-RA. Review.

PMID:
24576034
15.

Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors.

Larson AR, Dresser KA, Zhan Q, Lezcano C, Woda BA, Yosufi B, Thompson JF, Scolyer RA, Mihm MC Jr, Shi YG, Murphy GF, Lian CG.

Mod Pathol. 2014 Jul;27(7):936-44. doi: 10.1038/modpathol.2013.224. Epub 2014 Jan 3.

16.

Advances in understanding the pathogenesis of HLH.

Usmani GN, Woda BA, Newburger PE.

Br J Haematol. 2013 Jun;161(5):609-22. doi: 10.1111/bjh.12293. Epub 2013 Apr 12. Review.

PMID:
23577835
17.

A combination treatment approach and cord blood stem cell transplant for blastic plasmacytoid dendritic cell neoplasm.

Ramanathan M, Cerny J, Yu H, Woda BA, Nath R.

Haematologica. 2013 Mar;98(3):e36. doi: 10.3324/haematol.2012.080051. Epub 2013 Jan 8. No abstract available.

18.

Transformation of follicular lymphoma to Epstein-Barr virus-related Hodgkin-like lymphoma.

Menon MP, Hutchinson L, Garver J, Jaffe ES, Woda BA.

J Clin Oncol. 2013 Feb 10;31(5):e53-6. doi: 10.1200/JCO.2012.43.2377. Epub 2013 Jan 7. No abstract available.

19.

Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.

Lian CG, Xu Y, Ceol C, Wu F, Larson A, Dresser K, Xu W, Tan L, Hu Y, Zhan Q, Lee CW, Hu D, Lian BQ, Kleffel S, Yang Y, Neiswender J, Khorasani AJ, Fang R, Lezcano C, Duncan LM, Scolyer RA, Thompson JF, Kakavand H, Houvras Y, Zon LI, Mihm MC Jr, Kaiser UB, Schatton T, Woda BA, Murphy GF, Shi YG.

Cell. 2012 Sep 14;150(6):1135-46. doi: 10.1016/j.cell.2012.07.033.

20.

ATM phosphorylation of Mdm2 Ser394 regulates the amplitude and duration of the DNA damage response in mice.

Gannon HS, Woda BA, Jones SN.

Cancer Cell. 2012 May 15;21(5):668-79. doi: 10.1016/j.ccr.2012.04.011.

21.

Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations.

Jagadeesh D, Woda BA, Draper J, Evens AM.

Curr Treat Options Oncol. 2012 Mar;13(1):122-36. doi: 10.1007/s11864-011-0177-x. Review.

PMID:
22241590
22.

IMP3, a new biomarker to predict progression of cervical intraepithelial neoplasia into invasive cancer.

Lu D, Yang X, Jiang NY, Woda BA, Liu Q, Dresser K, Mercurio AM, Rock KL, Jiang Z.

Am J Surg Pathol. 2011 Nov;35(11):1638-45. doi: 10.1097/PAS.0b013e31823272d4.

PMID:
21997684
23.

The oncofetal protein IMP3: a novel molecular marker to predict aggressive meningioma.

Hao S, Smith TW, Chu PG, Liu Q, Ok CY, Woda BA, Lu D, Lin P, Wang SA, Dresser K, Rock KL, Jiang Z.

Arch Pathol Lab Med. 2011 Aug;135(8):1032-6. doi: 10.5858/2009-0652-OAR2.

PMID:
21809995
24.

Oncofetal protein IMP3, a new diagnostic biomarker to distinguish malignant mesothelioma from reactive mesothelial proliferation.

Shi M, Fraire AE, Chu P, Cornejo K, Woda BA, Dresser K, Rock KL, Jiang Z.

Am J Surg Pathol. 2011 Jun;35(6):878-82. doi: 10.1097/PAS.0b013e318218985b.

PMID:
21566519
25.

IMP2 expression distinguishes endometrioid from serous endometrial adenocarcinomas.

Zhang L, Liu Y, Hao S, Woda BA, Lu D.

Am J Surg Pathol. 2011 Jun;35(6):868-72. doi: 10.1097/PAS.0b013e318219c6f9.

PMID:
21566514
26.

Anaplastic lymphoma kinase-positive large B-cell lymphoma with complex karyotype and novel ALK gene rearrangements.

Shi M, Miron PM, Hutchinson L, Woda BA, Nath R, Cerny J, Yu H.

Hum Pathol. 2011 Oct;42(10):1562-7. doi: 10.1016/j.humpath.2011.01.012. Epub 2011 Apr 15.

PMID:
21497367
27.

High-level CD34 expression on megakaryocytes independently predicts an adverse outcome in patients with myelodysplastic syndromes.

Tang G, Wang SA, Menon M, Dresser K, Woda BA, Hao S.

Leuk Res. 2011 Jun;35(6):766-70. doi: 10.1016/j.leukres.2011.01.009. Epub 2011 Mar 1.

PMID:
21367453
28.

Infection with viruses from several families triggers autoimmune diabetes in LEW*1WR1 rats: prevention of diabetes by maternal immunization.

Tirabassi RS, Guberski DL, Blankenhorn EP, Leif JH, Woda BA, Liu Z, Winans D, Greiner DL, Mordes JP.

Diabetes. 2010 Jan;59(1):110-8. doi: 10.2337/db09-0255. Epub 2009 Sep 30.

29.

Chronic basophilic leukemia: a rare form of chronic myeloproliferative neoplasm.

Tang G, Woods LJ, Wang SA, Brettler D, Andersen M, Miron PM, Pechet L, Woda BA, Hao S.

Hum Pathol. 2009 Aug;40(8):1194-9. doi: 10.1016/j.humpath.2009.02.011. Epub 2009 May 8.

PMID:
19427022
30.

The utility of flow cytometric immunophenotyping in cytopenic patients with a non-diagnostic bone marrow: a prospective study.

Truong F, Smith BR, Stachurski D, Cerny J, Medeiros LJ, Woda BA, Wang SA.

Leuk Res. 2009 Aug;33(8):1039-46. doi: 10.1016/j.leukres.2009.01.012. Epub 2009 Feb 18.

PMID:
19232722
31.

Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveats.

Wang SA, Pozdnyakova O, Jorgensen JL, Medeiros LJ, Stachurski D, Anderson M, Raza A, Woda BA.

Haematologica. 2009 Jan;94(1):29-37. doi: 10.3324/haematol.13601. Epub 2008 Nov 10.

32.

Erythroid-predominant myelodysplastic syndromes: enumeration of blasts from nonerythroid rather than total marrow cells provides superior risk stratification.

Wang SA, Tang G, Fadare O, Hao S, Raza A, Woda BA, Hasserjian RP.

Mod Pathol. 2008 Nov;21(11):1394-402. doi: 10.1038/modpathol.2008.142. Epub 2008 Sep 12.

33.

Combination of quantitative IMP3 and tumor stage: a new system to predict metastasis for patients with localized renal cell carcinomas.

Jiang Z, Chu PG, Woda BA, Liu Q, Balaji KC, Rock KL, Wu CL.

Clin Cancer Res. 2008 Sep 1;14(17):5579-84. doi: 10.1158/1078-0432.CCR-08-0504.

34.

Expanded CD34+ human umbilical cord blood cells generate multiple lymphohematopoietic lineages in NOD-scid IL2rgamma(null) mice.

Giassi LJ, Pearson T, Shultz LD, Laning J, Biber K, Kraus M, Woda BA, Schmidt MR, Woodland RT, Rossini AA, Greiner DL.

Exp Biol Med (Maywood). 2008 Aug;233(8):997-1012. doi: 10.3181/0802-RM-70.

35.

Sp1, a new biomarker that identifies a subset of aggressive pancreatic ductal adenocarcinoma.

Jiang NY, Woda BA, Banner BF, Whalen GF, Dresser KA, Lu D.

Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1648-52. doi: 10.1158/1055-9965.EPI-07-2791.

36.

Eosinophilia with FIP1L1-PDGFRA fusion in a patient with chronic myelomonocytic leukemia.

Zota V, Miron PM, Woda BA, Raza A, Wang SA.

J Clin Oncol. 2008 Apr 20;26(12):2040-1. doi: 10.1200/JCO.2007.15.3841. No abstract available. Erratum in: J Clin Oncol. 2008 Jun;26(18):3110.

PMID:
18421057
37.

Oncofetal protein IMP3: a novel molecular marker that predicts metastasis of papillary and chromophobe renal cell carcinomas.

Jiang Z, Lohse CM, Chu PG, Wu CL, Woda BA, Rock KL, Kwon ED.

Cancer. 2008 Jun 15;112(12):2676-82. doi: 10.1002/cncr.23484.

38.

IMP3 predicts aggressive superficial urothelial carcinoma of the bladder.

Sitnikova L, Mendese G, Liu Q, Woda BA, Lu D, Dresser K, Mohanty S, Rock KL, Jiang Z.

Clin Cancer Res. 2008 Mar 15;14(6):1701-6. doi: 10.1158/1078-0432.CCR-07-2039.

39.

Hypersensitivity pneumonitis: an immunopathology review.

Woda BA.

Arch Pathol Lab Med. 2008 Feb;132(2):204-5. doi: 10.1043/1543-2165(2008)132[204:HPAIR]2.0.CO;2. Review.

PMID:
18251577
40.

Expression of the translation initiation factors eIF-4E and eIF-2* is frequently increased in neoplastic cells of Hodgkin lymphoma.

Rosenwald IB, Koifman L, Savas L, Chen JJ, Woda BA, Kadin ME.

Hum Pathol. 2008 Jun;39(6):910-6. doi: 10.1016/j.humpath.2007.10.021. Epub 2008 Jan 30.

PMID:
18234281
41.

A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene.

King M, Pearson T, Shultz LD, Leif J, Bottino R, Trucco M, Atkinson MA, Wasserfall C, Herold KC, Woodland RT, Schmidt MR, Woda BA, Thompson MJ, Rossini AA, Greiner DL.

Clin Immunol. 2008 Mar;126(3):303-14. Epub 2007 Dec 21.

PMID:
18096436
42.

Hypocellularity in myelodysplastic syndrome is an independent factor which predicts a favorable outcome.

Yue G, Hao S, Fadare O, Baker S, Pozdnyakova O, Galili N, Woda BA, Raza A, Wang SA.

Leuk Res. 2008 Apr;32(4):553-8. Epub 2007 Sep 20.

PMID:
17888511
43.

Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations.

Li C, Zota V, Woda BA, Rock KL, Fraire AE, Jiang Z, Lu D, Xu B, Dresser K, Lutman CV, Fischer AH.

Mod Pathol. 2007 Dec;20(12):1263-8. Epub 2007 Sep 21.

45.

Myelodysplastic syndrome with pure red cell aplasia shows characteristic clinicopathological features and clonal T-cell expansion.

Wang SA, Yue G, Hutchinson L, Landry ML, Hasserjian RP, Hao S, Galili N, Raza A, Woda BA.

Br J Haematol. 2007 Jul;138(2):271-5. Epub 2007 Jun 3. No abstract available.

PMID:
17542981
46.

IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expression.

Li C, Rock KL, Woda BA, Jiang Z, Fraire AE, Dresser K.

Mod Pathol. 2007 Feb;20(2):242-7. Epub 2006 Dec 22.

47.

Mosaic tetraploidy and transient GFI1 mutation in a patient with severe chronic neutropenia.

Hochberg JC, Miron PM, Hay BN, Woda BA, Wang SA, Richert-Przygonska M, Aprikyan AA, Newburger PE.

Pediatr Blood Cancer. 2008 Mar;50(3):630-2.

PMID:
17096407
48.

Autoimmunity after islet-cell allotransplantation.

Worcester Human Islet Transplantation Group, Sharma V, Andersen D, Thompson M, Woda BA, Stoff JS, Hartigan C, Rastellini C, Phillips D, Mordes JP, Rossini AA.

N Engl J Med. 2006 Sep 28;355(13):1397-9. No abstract available.

PMID:
17005967
49.
50.

Acute lymphocytic leukemia with eosinophilia and unusual karyotype.

Rezk S, Wheelock L, Fletcher JA, Oliveira AM, Keuker CP, Newburger PE, Xu B, Woda BA, Miron PM.

Leuk Lymphoma. 2006 Jun;47(6):1176-9. No abstract available.

Supplemental Content

Support Center